<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Sabaté, M.</title>
    <link>http://repub.eur.nl/res/aut/802/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Initial observation regarding changes in vessel dimensions after balloon angioplasty and stenting followed by catheter-based beta-radiation. Is stenting necessary in the setting of catheter-based radiotherapy? (Article)</title>
      <link>http://repub.eur.nl/res/pub/13059/</link>
      <pubDate>2002-04-01T00:00:00Z</pubDate>
      <description>AIMS: We sought to compare the effect of intracoronary beta-radiation on the vessel dimensions in de novo lesions using three-dimensional intravascular ultrasound quantification after balloon angioplasty and stenting. METHODS AND RESULTS: Forty patients (44 vessels; 28 balloon angioplasty and 16 stenting) treated with catheter-based beta-radiation and 18 non-irradiated control patients (18 vessels; 10 balloon angioplasty and 8 stenting) were investigated by means of three-dimensional volumetric intravascular ultrasound analysis post-procedure and at 6-8 months follow-up. Total vessel (EEM) volume enlarged after both balloon angioplasty and stenting (+37 mm(3) vs +42 mm(3), P=ns), but vessel wall volume (plaque plus media) also increased similarly (+33 mm(3) vs +49 mm(3), P=ns) in the irradiated patients. Lumen volume remained unchanged in both groups (+3 mm(3) vs -7 mm(3), P=ns). In the stent-covered segments, neointima at follow-up was significantly smaller in the irradiated group than the control group (8 mm(3) vs 27 mm(3), P=0.001, respectively), but the total amount of tissue growth was similar in both groups (33 mm(3) vs 29 mm(3), P=ns). CONCLUSIONS: Intracoronary beta-radiation induces vessel enlargement after balloon angioplasty and/or stenting, accommodating tissue growth. Additional stenting may not play an important role in the prevention of constrictive remodelling in the setting of catheter-based intracoronary beta-radiotherapy.</description>
    </item> <item>
      <title>Clinical and angiographical follow-up after implantation of a 6--12 microCi radioactive stent in patients with coronary artery disease. (Article)</title>
      <link>http://repub.eur.nl/res/pub/12923/</link>
      <pubDate>2001-07-19T00:00:00Z</pubDate>
      <description>AIMS: This study is the contribution by the Thoraxcenter, Rotterdam, to the European(32)P Dose Response Trial, a non-randomized multicentre trial to evaluate the safety and efficacy of the radioactive Isostent in patients with single coronary artery disease. METHODS AND RESULTS: The radioactivity of the stent at implantation was 6--12 microCi. All patients received aspirin indefinitely and either ticlopidine or clopidogrel for 3 months. Quantitative coronary angiography measurements of both the stent area and the target lesion (stent area and up to 5 mm proximal and distal to the stent edges) were performed pre- and post-procedure and at the 5-month follow-up. Forty-two radioactive stents were implanted in 40 patients. Treated vessels were the left anterior descending coronary artery (n=20), right coronary artery (n=10) or left circumflex artery (n=10). Eight patients received additional non-radioactive stents. Lesion length measured 10+/-3 mm with a reference diameter of 3.07+/-0.69 mm. Minimal lumen diameter increased from 0.98+/-0.53 mm pre-procedure to 2.29+/-0.52 mm (target lesion) and 2.57+/-0.44 mm (stent area) post-procedure. There was one procedural non-Q wave myocardial infarction, due to transient thrombotic closure. Thirty-six patients returned for angiographical follow-up. Two patients had a total occlusion proximal to the radioactive stent. Of the patent vessels, none had in-stent restenosis. Edge restenosis was observed in 44%, occurring predominantly at the proximal edge. Target lesion revascularization was performed in 10 patients and target vessel revascularization in one patient. No additional clinical end-points occurred during follow-up. The minimal lumen diameter at follow-up averaged 1.66+/-0.71 mm (target lesion) and 2.12+/-0.72 (stent area); therefore late loss was 0.63+/-0.69 (target lesion) and 0.46+/-0.76 (stent area), resulting in a late loss index of 0.65+/-1.15 (target lesion) and 0.30+/-0.53 (stent area). CONCLUSION: These results indicate that the use of radioactive stents is safe and feasible, however, the high incidence of edge restenosis makes this technique currently clinically non-applicable.</description>
    </item> <item>
      <title>Three dimensional intravascular ultrasonic assessment of the local mechanism of restenosis after balloon angioplasty (Article)</title>
      <link>http://repub.eur.nl/res/pub/8349/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: To assess the mechanism of restenosis after balloon angioplasty. DESIGN: Prospective study. PATIENTS: 13 patients treated with balloon angioplasty. INTERVENTIONS: 111 coronary subsegments (2 mm each) were analysed after balloon angioplasty and at a six month follow up using three dimensional intravascular ultrasound (IVUS). MAIN OUTCOME MEASURES: Qualitative and quantitative IVUS analysis. Total vessel (external elastic membrane), plaque, and lumen volume were measured in each 2 mm subsegment. Delta values were calculated (follow up - postprocedure). Remodelling was defined as any (positive or negative) change in total vessel volume. RESULTS: Positive remodelling was observed in 52 subsegments while negative remodelling occurred in 44. Remodelling, plaque type, and dissection were heterogeneously distributed along the coronary segments. Plaque composition was not associated with changes in IVUS indices, whereas dissected subsegments had a greater increase in total vessel volume than those without dissection (1.7 mm(3) v -0.33 mm(3), p = 0.04). Change in total vessel volume was correlated with changes in lumen (p &lt; 0.05, r = 0.56) and plaque volumes (p &lt; 0.05, r = 0.64). The site with maximum lumen loss was not the same site as the minimum lumen area at follow up in the majority (n = 10) of the vessels. In the multivariate model, residual plaque burden had an influence on negative remodelling (p = 0.001, 95% confidence interval (CI) -0.391 to -0.108), whereas dissection had an effect on total vessel increase (p = 0.002, 95% CI 1.168 to 4.969). CONCLUSIONS: The mechanism of lumen renarrowing after balloon angioplasty appears to be determined by unfavourable remodelling. However, different patterns of remodelling may occur in individual injured coronary segments, which highlights the complexity and influence of local factors in the restenotic process.</description>
    </item> <item>
      <title>Relationship between tensile stress and plaque growth after balloon angioplasty treated with and without intracoronary beta-brachytherapy. (Article)</title>
      <link>http://repub.eur.nl/res/pub/12895/</link>
      <pubDate>2000-12-01T00:00:00Z</pubDate>
      <description>AIMS: We investigated the influence of tensile stress on plaque growth after balloon angioplasty with and without beta-radiation therapy. METHODS AND RESULTS: Thirty-one consecutive patients successfully treated with balloon angioplasty were analysed qualitatively and quantitatively by means of an ECG-gated three-dimensional intravascular ultrasound post-procedure and at follow-up. Eighteen patients were irradiated with catheter-based beta-radiation ((90)Sr/(90)Y source) and 13 were not (control). Studied segments were divided into 2 mm subsegments. Thus 184 irradiated and 111 non-irradiated subsegments were included. Tensile stress was calculated according to Laplace's law. The radiation dose was calculated by means of dose-volume histograms. Plaque growth was positively correlated to tensile stress in both the radiation and control groups (r=0.374, P=0.0001 and r=0.305, P=0.001). Low-dose subsegments (&lt;6 Gy) had a significant correlation (r=0.410, P=0.0001) whereas no correlation was observed in the effective-dose subsegments (&gt; or = 6 Gy). Multivariate analysis identified tensile stress as the only independent predictor of plaque increase in non-irradiated subsegments, whereas actual dose and plaque morphology were stronger predictors in irradiated subsegments. CONCLUSION: The results of this study suggest that plaque growth is related to tensile stress after balloon angioplasty. Intracoronary brachytherapy may alter the biophysical process on plaque growth when the prescribed dose is effectively delivered.</description>
    </item> <item>
      <title>Intracoronary Brachytherapy: a New Technique to Prevent Restenosis After Percutaneous Coronary Interventions (Doctoral Thesis)</title>
      <link>http://repub.eur.nl/res/pub/21111/</link>
      <pubDate>2000-05-10T00:00:00Z</pubDate>
      <description>Percutaneous trans luminal coronary angioplasty (PTCA) is an accepted treatment for
coronary artery disease. However, angiographical restenosis is reported in 40-60% of patients
after a successful PTCA. Mechanisms involved in the restenosis process are elastic recoil of
the artery, local thrombus formation, vascular remodeling with shrinkage of the vessel and an
overact healing process with neointimal hyperplasia. 
Neointimal hyperplasia develops by
migration and proliferation of smooth muscle cells and myofibroblasts after balloon induced
trauma of the arterial wall and by deposition of an extracellular matrix by the smooth muscle
cells. The introduction of the stent in the arsenal of the interventional cardiologist has reduced
the restenosis rate to 15-20%, by preventing elastic recoil and negative remodeling.
However, the occurrence of restenosis after stent implantation remains unresolved, especially in
small vessels and long lesions, where it may exceed 30% of the cases. It is primary caused by
neointimal hyperplasia, which occurs due to trauma of the arterial wall by the stent-struts. The
treatment of in-stent restenosis with conventional techniques (balloon angioplasty or debulking)
is rather disappointing with restenosis rates of 27-63%, which increases with the number of reinterventions.
Since radiotherapy had proven to be effective in treating the exuberant fibroblastic activity of
keloid scar formation and other non-malignant processes such as ocular pterygia it was
assumed that this adjunctive therapy would also inhibit coronary restenosis.</description>
    </item> <item>
      <title>Three-dimensional intravascular ultrasonic volumetric quantification of stent recoil and neointimal formation of two new generation tubular stents (Article)</title>
      <link>http://repub.eur.nl/res/pub/4905/</link>
      <pubDate>2000-01-15T00:00:00Z</pubDate>
      <description>Currently, several different designs of coronary stents are available. However, only a few of the new generation stents have been investigated in large randomized trials. Mechanical behavior of first-generation stents (Palmaz-Schatz, Gianturco-Roubin) may not be applied to the new designs. We investigated the chronic mechanical behavior (recoil) of 2 stents recently approved by the Food and Drug Administration (MULTILINK and NIR). Forty-eight patients with single-stent implantation (23 MULTILINK and 25 NIR) were assessed by means of volumetric 3-dimensional intravascular ultrasound analysis after the procedure and at 6-month follow-up. In addition, volumetric assessment of neointimal formation was performed. No significant chronic stent recoil was detected in both groups (Δ MULTILINK stent volume: +5.6 ± 41 mm3 [p = NS] and Δ NIR stent volume + 2.1 ± 26 mm3 [p = NS]). A similar degree of neointimal formation at 6 months was observed between the 2 stents (MULTILINK 46 ± 31.9 mm3 vs NIR 39.9 ± 27.6 mm3, p = NS). In conclusion, these 2 second-generation tubular stents did not show chronic recoil and appeared to promote similar proliferative response after implantation in human coronary arteries.</description>
    </item> <item>
      <title>Positive Geometric Vascular Remodeling Is Seen After Catheter-Based Radiation Followed by Conventional Stent Implantation but Not After Radioactive Stent Implantation (Article)</title>
      <link>http://repub.eur.nl/res/pub/4868/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>Background—Recent reports demonstrate that intracoronary radiation affects not only neointimal formation but also vascular remodeling. Radioactive stents and catheter-based techniques deliver radiation in different ways, suggesting that different patterns of remodeling after each technique may be expected.

Methods and Results—We analyzed remodeling in 18 patients after conventional stent implantation, 16 patients after low-activity radioactive stent implantation, 16 patients after higher activity radioactive stent implantation, and, finally, 17 patients who underwent catheter-based radiation followed by conventional stent implantation. Intravascular ultrasound with 3D reconstruction was used after stent implantation and at the 6-month follow-up to assess remodeling within the stent margins and at its edges. Preprocedural characteristics were similar between groups. In-stent neointimal hyperplasia (NIH) was inhibited by high-activity radioactive stent implantation (NIH 9.0 mm3) and by catheter-based radiation followed by conventional stent implantation (NIH 6.9 mm3) compared with low-activity radioactive stent implantation (NIH 21.2 mm3) and conventional stent implantation (NIH 20.8 mm3) (P=0.008). No difference in plaque or total vessel volume was seen behind the stent in the conventional, low-activity, or high-activity stent implantation groups. However, significant increases in plaque behind the stent (15%) and in total vessel volume (8%) were seen in the group that underwent catheter-based radiation followed by conventional stent implantation. All 4 groups demonstrated significant late lumen loss at the stent edges; however, edge restenosis was seen only in the group subjected to high-activity stent implantation and appeared to be due to an increase in plaque and, to a lesser degree, to negative remodeling.

Conclusions—Distinct differences in the patterns of remodeling exist between conventional, radioactive, and catheter-based radiotherapy with stenting.</description>
    </item> <item>
      <title>Residual Plaque Burden, Delivered Dose, and Tissue Composition Predict 6-Month Outcome After Balloon Angioplasty and Beta-Radiation Therapy (Article)</title>
      <link>http://repub.eur.nl/res/pub/4888/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>Background—Inhomogeneity of dose distribution and anatomic aspects of the atherosclerotic plaque may influence the outcome of irradiated lesions after balloon angioplasty (BA). We evaluated the influence of delivered dose and morphological characteristics of coronary stenoses treated with ß-radiation after BA.

Methods and Results—Eighteen consecutive patients treated according to the Beta Energy Restenosis Trial 1.5 were included in the study. The site of angioplasty was irradiated with the use of a ß-emitting 90Sr/90Y source. With the side branches used as anatomic landmarks, the irradiated area was identified and volumetric assessment was performed by 3D intracoronary ultrasound imaging after treatment and at 6 months. The type of tissue, the presence of dissection, and the vessel volumes were assessed every 2 mm within the irradiated area. The minimal dose absorbed by 90% of the adventitial volume (Dv90Adv) was calculated in each 2-mm segment. Diffuse calcified subsegments and those containing side branches were excluded. Two hundred six coronary subsegments were studied. Of those, 55 were defined as soft, 129 as hard, and 22 as normal/intimal thickening. Plaque volume showed less increase in hard segments as compared with soft and normal/intimal thickening segments (P&lt;0.0001). Dv90Adv was associated with plaque volume at follow-up after a polynomial equation with linear and nonlinear components (r=0.71; P=0.0001). The multivariate regression analysis identified the independent predictors of the plaque volume at follow-up: plaque volume after treatment, Dv90Adv, and type of plaque.

Conclusions—Residual plaque burden, delivered dose, and tissue composition play a fundamental role in the volumetric outcome at 6-month follow-up after ß-radiation therapy and BA.</description>
    </item> <item>
      <title>Geographic Miss (Article)</title>
      <link>http://repub.eur.nl/res/pub/4889/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>Background—A recognized limitation of endovascular ß-radiation therapy is the development of new stenosis at the edges of the irradiated area. The combination of injury and low-dose radiation may be the precursor of this phenomenon. We translated the radio-oncological concept of "geographic miss" to define cases in which the radiation source did not fully cover the injured area. The aims of the study were to determine the incidence and causes of geographic miss and evaluate the impact of this inadequate treatment on the outcome of patients treated with intracoronary ß-radiation.

Methods and Results—We analyzed 50 consecutive patients treated with ß-radiation after percutaneous coronary intervention. The prescribed dose ranged between 12 and 20 Gy at 2 mm from the source axis. By means of quantitative coronary angiography, the irradiated segment (IRS) and both edges were studied before and after intervention and at 6-month follow-up. Edges that were injured during the procedure constituted the geographic miss edges. Twenty-two edges were injured during the intervention, mainly because of procedural complications that extended the treatment beyond the margins of the IRS. Late loss was significantly higher in geographic miss edges than in IRSs and uninjured edges (0.84±0.6 versus 0.15±0.4 and 0.09±0.4 mm, respectively; P&lt;0.0001). Similarly, restenosis rate was significantly higher in the injured edges (10% within IRS, 40.9% in geographic miss edges, and 1.9% in uninjured edges; P&lt;0.001).

Conclusions—These data support the hypothesis that the combination of injury and low-dose ß-radiation induces deleterious outcome.</description>
    </item> <item>
      <title>Coronary bifurcation stenting using dedicated bifurcation stents (Article)</title>
      <link>http://repub.eur.nl/res/pub/4909/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>We report three cases of successful implantation of three different stents specially designed for bifurcation lesions, guided by intracoronary ultrasound. The BARD and AVE are true bifurcated stents for side-branch access and the NIR-Side Royal is a single modified NIR stent with an aperture to allow provisional bifurcation stenting. These designs introduce a new era in percutaneous management of coronary bifurcation lesions. Cathet. Cardiovasc. Intervent. 49:105–111, 2000.</description>
    </item> <item>
      <title>Outcome from balloon induced coronary artery dissection after intracoronary beta radiation (Article)</title>
      <link>http://repub.eur.nl/res/pub/8353/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: To evaluate the healing of balloon induced coronary artery
      dissection in individuals who have received beta radiation treatment and
      to propose a new intravascular ultrasound (IVUS) dissection score to
      facilitate the comparison of dissection through time. DESIGN:
      Retrospective study. SETTING: Tertiary referral centre. PATIENTS: 31
      patients with stable angina pectoris, enrolled in the beta energy
      restenosis trial (BERT-1.5), were included. After excluding those who
      underwent stent implantation, the evaluable population was 22 patients.
      INTERVENTIONS: Balloon angioplasty and intracoronary radiation followed by
      quantitative coronary angiography (QCA) and IVUS. Repeat QCA and IVUS were
      performed at six month follow up. MAIN OUTCOME MEASURES: QCA and IVUS
      evidence of healing of dissection. Dissection classification for
      angiography was by the National Heart Lung Blood Institute scale. IVUS
      proven dissection was defined as partial or complete. The following IVUS
      defined characteristics of dissection were described in the affected
      coronary segments: length, depth, arc circumference, presence of flap, and
      dissection score. Dissection was defined as healed when all features of
      dissection had resolved. The calculated dose of radiation received by the
      dissected area in those with healed versus non-healed dissection was also
      compared. RESULTS: Angiography (type A = 5, B = 7, C = 4) and IVUS proven
      (partial = 12, complete = 4) dissections were seen in 16 patients
      following intervention. At six month follow up, six and eight unhealed
      dissections were seen by angiography (A = 2, B = 4) and IVUS (partial = 7,
      complete = 1), respectively. The mean IVUS dissection score was 5.2 (range
      3-8) following the procedure, and 4.6 (range 3-7) at follow up. No
      correlation was found between the dose prescribed in the treated area and
      the presence of unhealed dissection. No change in anginal status was seen
      despite the presence of unhealed dissection. CONCLUSION: beta radiation
      appears to alter the normal healing process, resulting in unhealed
      dissection in certain individuals. In view of the delayed and abnormal
      healing observed, long term follow up is indicated given the possible late
      adverse effects of radiation. Although in this cohort no increase in
      cardiac events following coronary dissections was seen, larger populations
      are needed to confirm this phenomenon. Stenting of all coronary
      dissections may be warranted in patients scheduled for brachytherapy after
      balloon angioplasty.</description>
    </item> <item>
      <title>Diagnosis of an Intracoronary Thrombus With Intravascular Ultrasound (Article)</title>
      <link>http://repub.eur.nl/res/pub/9280/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>A60-year-old man was referred for coronary angiography because of exertional angina (Canadian Cardiovascular Society angina classification type II). Twelve years earlier, he had had a myocardial infarction with a venous bypass graft to the right coronary artery.</description>
    </item> <item>
      <title>Geographic miss: a cause of treatment failure in radio-oncology applied to intracoronary radiation therapy (Article)</title>
      <link>http://repub.eur.nl/res/pub/9373/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: A recognized limitation of endovascular beta-radiation therapy
      is the development of new stenosis at the edges of the irradiated area.
      The combination of injury and low-dose radiation may be the precursor of
      this phenomenon. We translated the radio-oncological concept of
      "geographic miss" to define cases in which the radiation source did not
      fully cover the injured area. The aims of the study were to determine the
      incidence and causes of geographic miss and evaluate the impact of this
      inadequate treatment on the outcome of patients treated with intracoronary
      beta-radiation. METHODS AND RESULTS: We analyzed 50 consecutive patients
      treated with beta-radiation after percutaneous coronary intervention. The
      prescribed dose ranged between 12 and 20 Gy at 2 mm from the source axis.
      By means of quantitative coronary angiography, the irradiated segment
      (IRS) and both edges were studied before and after intervention and at
      6-month follow-up. Edges that were injured during the procedure
      constituted the geographic miss edges. Twenty-two edges were injured
      during the intervention, mainly because of procedural complications that
      extended the treatment beyond the margins of the IRS. Late loss was
      significantly higher in geographic miss edges than in IRSs and uninjured
      edges (0.84+/-0.6 versus 0.15+/-0.4 and 0.09+/-0.4 mm, respectively;
      P&lt;0.0001). Similarly, restenosis rate was significantly higher in the
      injured edges (10% within IRS, 40.9% in geographic miss edges, and 1.9% in
      uninjured edges; P&lt;0.001). CONCLUSIONS: These data support the hypothesis
      that the combination of injury and low-dose beta-radiation induces
      deleterious outcome.</description>
    </item> <item>
      <title>Residual plaque burden, delivered dose, and tissue composition predict 6-month outcome after balloon angioplasty and beta-radiation therapy (Article)</title>
      <link>http://repub.eur.nl/res/pub/9374/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Inhomogeneity of dose distribution and anatomic aspects of the
      atherosclerotic plaque may influence the outcome of irradiated lesions
      after balloon angioplasty (BA). We evaluated the influence of delivered
      dose and morphological characteristics of coronary stenoses treated with
      beta-radiation after BA. METHODS AND RESULTS: Eighteen consecutive
      patients treated according to the Beta Energy Restenosis Trial 1.5 were
      included in the study. The site of angioplasty was irradiated with the use
      of a beta-emitting (90)Sr/(90)Y source. With the side branches used as
      anatomic landmarks, the irradiated area was identified and volumetric
      assessment was performed by 3D intracoronary ultrasound imaging after
      treatment and at 6 months. The type of tissue, the presence of dissection,
      and the vessel volumes were assessed every 2 mm within the irradiated
      area. The minimal dose absorbed by 90% of the adventitial volume
      (D(v90)Adv) was calculated in each 2-mm segment. Diffuse calcified
      subsegments and those containing side branches were excluded. Two hundred
      six coronary subsegments were studied. Of those, 55 were defined as soft,
      129 as hard, and 22 as normal/intimal thickening. Plaque volume showed
      less increase in hard segments as compared with soft and normal/intimal
      thickening segments (P&lt;0.0001). D(v90)Adv was associated with plaque
      volume at follow-up after a polynomial equation with linear and nonlinear
      components (r = 0.71; P = 0.0001). The multivariate regression analysis
      identified the independent predictors of the plaque volume at follow-up:
      plaque volume after treatment, D(v90)Adv, and type of plaque. CONCLUSIONS:
      Residual plaque burden, delivered dose, and tiss composition play a
      fundamental role in the volumetric outcome at 6-month follow-up after
      beta-radiation therapy and BA.</description>
    </item> <item>
      <title>Positive geometric vascular remodeling is seen after catheter-based radiation followed by conventional stent implantation but not after radioactive stent implantation (Article)</title>
      <link>http://repub.eur.nl/res/pub/9460/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Recent reports demonstrate that intracoronary radiation
      affects not only neointimal formation but also vascular remodeling.
      Radioactive stents and catheter-based techniques deliver radiation in
      different ways, suggesting that different patterns of remodeling after
      each technique may be expected. METHODS AND RESULTS: We analyzed
      remodeling in 18 patients after conventional stent implantation, 16
      patients after low-activity radioactive stent implantation, 16 patients
      after higher activity radioactive stent implantation, and, finally, 17
      patients who underwent catheter-based radiation followed by conventional
      stent implantation. Intravascular ultrasound with 3D reconstruction was
      used after stent implantation and at the 6-month follow-up to assess
      remodeling within the stent margins and at its edges. Preprocedural
      characteristics were similar between groups. In-stent neointimal
      hyperplasia (NIH) was inhibited by high-activity radioactive stent
      implantation (NIH 9.0 mm(3)) and by catheter-based radiation followed by
      conventional stent implantation (NIH 6.9 mm(3)) compared with low-activity
      radioactive stent implantation (NIH 21.2 mm(3)) and conventional stent
      implantation (NIH 20.8 mm(3)) (P:=0.008). No difference in plaque or total
      vessel volume was seen behind the stent in the conventional, low-activity,
      or high-activity stent implantation groups. However, significant increases
      in plaque behind the stent (15%) and in total vessel volume (8%) were seen
      in the group that underwent catheter-based radiation followed by
      conventional stent implantation. All 4 groups demonstrated significant
      late lumen loss at the stent edges; however, edge restenosis was seen only
      in the group subjected to high-activity stent implantation and appeared to
      be due to an increase in plaque and, to a lesser degree, to negative
      remodeling. CONCLUSIONS: Distinct differences in the patterns of
      remodeling exist between conventional, radioactive, and catheter-based
      radiotherapy with stenting.</description>
    </item> <item>
      <title>Three-dimensional intravascular ultrasound assessment of noninjured edges of beta-irradiated coronary segments (Article)</title>
      <link>http://repub.eur.nl/res/pub/9470/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: The "edge effect," late lumen loss at the margins of the
      treated segment, has become an important issue in the field of coronary
      brachytherapy. The aim of the present study was to assess the edge effect
      in noninjured margins adjacent to the irradiated segments after
      catheter-based intracoronary beta-irradiation. METHODS AND RESULTS:
      Fifty-three vessels were assessed by means of 3-dimensional intravascular
      ultrasound after the procedure and at 6- to 8-month follow-up. Fourteen
      vessels (placebo group) did not receive radiation (sham source), whereas
      39 vessels were irradiated. In the irradiated group, 48 edges (5 mm in
      length) were identified as noninjured, whereas 18 noninjured edges were
      selected in the placebo group. We compared the volumetric intravascular
      ultrasound measurements of the noninjured edges of the irradiated vessels
      with the fully irradiated nonstented segments (IRS, n=27) (26-mm segments
      received the prescribed 100% isodose) and the noninjured edges of the
      vessels of the placebo patients. The lumen decreased (6 mm(3)) in the
      noninjured edges of the irradiated vessels at follow-up (P:=0. 001). We
      observed a similar increase in plaque volume in all segments: noninjured
      edges of the irradiated group (19.6%), noninjured edges of the placebo
      group (21.5%), and IRS (21.0%). The total vessel volume increased in the
      IRS in the 3 groups. No edge segment was subject to repeat
      revascularization. CONCLUSIONS: The edge effect occurs in the noninjured
      margins of radiation source train in both irradiated and placebo patients.
      Thus, low-dose radiation may not play an important role in this
      phenomenon, whereas nonmeasurable device injury may be considered a
      plausible alternative explanation.</description>
    </item> <item>
      <title>Comparison of brachytherapy strategies based on dose-volume histograms derived from quantitative intravascular ultrasound. (Article)</title>
      <link>http://repub.eur.nl/res/pub/4929/</link>
      <pubDate>1999-04-01T00:00:00Z</pubDate>
      <description>PURPOSE: We present in this paper the comparison, by simulation, of different treatment strategies based either on beta- or gamma-sources, both with and without a centering device. Ionizing radiation to prevent restenosis is an emerging modality in interventional cardiology. Numerous clinical studies are presently being performed or planned, but there is variability in dose prescription, and both gamma- and beta-emitters are used, leading to a wide range of possible dose distributions over the arterial vessel wall. This paper discusses the potential merits of dose-volume histograms (DVH) based on three-dimensional (3-D) reconstruction of electrocardiogram (ECG)-gated intravascular ultrasound (IVUS) to compare brachytherapy treatment strategies. MATERIALS AND METHODS: DVH describe the cumulative distribution of dose over three specific volumes: (1) at the level of the luminal surface, a volume was defined with a thickness of 0.1 mm from the automatically detected contour of the highly echogenic blood-vessel interface; (2) at the level of the IVUS echogenic media-adventitia interface (external elastic lamina [EEL]), an adventitial volume was computed considering a 0.5-mm thickness from EEL; and (3) the volume encompassed between the luminal surface and the EEL (plaque + media). The IVUS data used were recorded in 23 of 31 patients during the Beta Energy Restenosis Trial (BERT) conducted in our institution. RESULTS: On average, the minimal dose in 90% of the adventitial volume was 37 +/- 16% of the prescribed dose; the minimal dose in 90% of the plaque + media volume was 58 +/- 24% and of the luminal surface volume was 67 +/- 31%. The minimal dose in the 10% most exposed luminal surface volume was 296 +/- 42%. Simulations of the use of a gamma-emitter and/or a radioactive source train centered in the lumen are reported, with a comparison of the homogeneity of the dose distribution.</description>
    </item> <item>
      <title>Clinical implications of intravascular ultrasound imaging for stenting procedures. (Article)</title>
      <link>http://repub.eur.nl/res/pub/4930/</link>
      <pubDate>1999-02-15T00:00:00Z</pubDate>
      <description>While quantitative coronary angiography (QCA) remains the standard used to assess new interventional therapies, there is a growing interest in the use of intracoronary ultrasound (ICUS) as an additional imaging technique. During the past years, ICUS has taught us that even the most perfect angiogram after stent placement can be misleading. The study of Blessing et al1 in this
issue of the Journal shows that ICUS can be reliably used
for lumen measurements in stents and in reference segments.
However, it also showed a high variability between observers in the degree of stent expansion, which could lead to different therapeutic strategies. Is the clinical implication of this paper that ICUS is hard to use to determine optimal stenting results?
As the authors point out, many other studies are presenting
results of ICUS and stenting; but are those
studies comparable?</description>
    </item> <item>
      <title>Intracoronary ultrasound longitudinal reconstruction of a postangioplasty coronary artery dissection (Article)</title>
      <link>http://repub.eur.nl/res/pub/9132/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Late coronary occlusion after intracoronary brachytherapy (Article)</title>
      <link>http://repub.eur.nl/res/pub/9154/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Intracoronary brachytherapy appears to be a promising
      technology to prevent restenosis. Presently, limited data are available
      regarding the late safety of this therapeutic modality. The aim of the
      study was to determine the incidence of late (&gt;1 month) thrombosis after
      PTCA and radiotherapy. METHODS AND RESULTS: From April 1997 to March 1999,
      we successfully treated 108 patients with PTCA followed by intracoronary
      beta-radiation. Ninety-one patients have completed at least 2 months of
      clinical follow-up. Of these patients, 6.6% (6 patients) presented with
      sudden thrombotic events confirmed by angiography 2 to 15 months after
      intervention (2 balloon angioplasty and 4 stent). Some factors
      (overlapping stents, unhealed dissection) may have triggered the
      thrombosis process, but the timing of the event is extremely unusual.
      Therefore, the effect of radiation on delaying the healing process and
      maintaining a thrombogenic coronary surface is proposed as the most
      plausible mechanism to explain such late events. CONCLUSIONS: Late and
      sudden thrombosis after PTCA followed by intracoronary radiotherapy is a
      new phenomenon in interventional cardiology.</description>
    </item> <item>
      <title>Geometric vascular remodeling after balloon angioplasty and beta-radiation therapy: A three-dimensional intravascular ultrasound study (Article)</title>
      <link>http://repub.eur.nl/res/pub/9161/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Endovascular radiation appears to inhibit intimal thickening
      after overstretching balloon injury in animal models. The effect of
      brachytherapy on vascular remodeling is unknown. The aim of the study was
      to determine the evolution of coronary vessel dimensions after
      intracoronary irradiation after successful balloon angioplasty in humans.
      METHODS AND RESULTS: Twenty-one consecutive patients treated with balloon
      angioplasty and beta-radiation according to the Beta Energy Restenosis
      Trial-1.5 were included in the study. Volumetric assessment of the
      irradiated segment and both edges was performed after brachytherapy and at
      6-month follow-up. Intravascular ultrasound images were acquired by means
      of ECG-triggered pullback, and 3-D reconstruction was performed by
      automated edge detection, allowing the calculation of lumen, plaque, and
      external elastic membrane (EEM) volumes. In the irradiated segments, mean
      EEM and plaque volumes increased significantly (451+/-128 to 490.9+/-159
      mm(3) and 201.2+/-59 to 241.7+/-74 mm(3); P=0.01 and P=0.001,
      respectively), whereas luminal volume remained unchanged (250.8+/-91 to
      249.2+/-102 mm(3); P=NS). The edges demonstrated an increase in mean
      plaque volume (26.8+/-12 to 32. 6+/-10 mm(3), P=0.0001) and no net change
      in mean EEM volume (71. 4+/-24 to 70.9+/-24 mm(3), P=NS), resulting in a
      decrease in mean luminal volume (44.6+/-16 to 38.3+/-16 mm(3), P=0.01).
      CONCLUSIONS: A different pattern of remodeling is observed in coronary
      segments treated with beta-radiation after successful balloon angioplasty.
      In the irradiated segments, the adaptive increase of EEM volume appears to
      be the major contributor to the luminal volume at follow-up. Conversely,
      both edges showed an increase in plaque volume without a net change in EEM
      volume.</description>
    </item> <item>
      <title>Preserved endothelium-dependent vasodilation in coronary segments previously treated with balloon angioplasty and intracoronary irradiation (Article)</title>
      <link>http://repub.eur.nl/res/pub/9177/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Abnormal endothelium-dependent coronary vasomotion has been
      reported after balloon angioplasty (BA), as well as after intracoronary
      radiation. However, the long-term effect on coronary vasomotion is not
      known. The aim of this study was to evaluate the long-term vasomotion of
      coronary segments treated with BA and brachytherapy. METHODS AND RESULTS:
      Patients with single de novo lesions treated either with BA followed by
      intracoronary beta-irradiation (according to the Beta Energy Restenosis
      Trial-1.5) or with BA alone were eligible. Of these groups, those patients
      in stable condition who returned for 6-month angiographic follow-up formed
      the study population (n=19, irradiated group and n=11, control group).
      Endothelium-dependent coronary vasomotion was assessed by selective
      infusion of serial doses of acetylcholine (ACh) proximally to the treated
      area. Mean luminal diameter was calculated by quantitative coronary
      angiography both in the treated area and in distal segments. Endothelial
      dysfunction was defined as a vasoconstriction after the maximal dose of
      ACh (10(-6) mol/L). Seventeen irradiated segments (89.5%) demonstrated
      normal endothelial function. In contrast, 10 distal nonirradiated segments
      (53%) and 5 control segments (45%) demonstrated endothelium-dependent
      vasoconstriction (-19+/-17% and -9.0+/-5%, respectively). Mean percentage
      of change in mean luminal diameter after ACh was significantly higher in
      irradiated segments (P=0.01). CONCLUSIONS: Endothelium-dependent
      vasomotion of coronary segments treated with BA followed by beta-radiation
      is restored in the majority of stable patients at 6-month follow-up. This
      functional response appeared to be better than those documented both in
      the distal segments and in segments treated with BA alone.</description>
    </item> <item>
      <title>beta-Particle-emitting radioactive stent implantation. A safety and feasibility study (Article)</title>
      <link>http://repub.eur.nl/res/pub/9179/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: This study represents the Heart Center Rotterdam's
      contribution to the Isostents for Restenosis Intervention Study, a
      nonrandomized multicenter trial evaluating the safety and feasibility of
      the radioactive Isostent in patients with single coronary artery disease.
      Restenosis after stent implantation is primarily caused by neointimal
      hyperplasia. In animal studies, beta-particle-emitting radioactive stents
      decrease neointimal hyperplasia by inhibiting smooth muscle cell
      proliferation. METHODS AND RESULTS: The radioisotope (32)P, a
      beta-particle emitter with a half-life of 14.3 days, was directly embedded
      into the Isostent. The calculated range of radioactivity was 0.75 to 1.5
      microCi. Quantitative coronary angiography measurements were performed
      before and after the procedure and at 6-month follow-up. A total of 31
      radioactive stents were used in 26 patients; 30 (97%) were successfully
      implanted, and 1 was embolized. Treated lesions were in the left anterior
      descending coronary artery (n=12), the right coronary artery (n=8), or the
      left circumflex coronary artery (n=6). Five patients received additional,
      nonradioactive stents. Treated lesion lengths were 13+/-4 mm, with a
      reference diameter of 2.93+/-0. 47 mm. Minimum lumen diameter increased
      from 0.87+/-0.28 mm preprocedure to 2.84+/-0.35 mm postprocedure. No
      in-hospital adverse cardiac events occurred. All patients received aspirin
      indefinitely and ticlopidine for 4 weeks. Twenty-three patients (88%)
      returned for 6-month angiographic follow-up; 17% of them had in-stent
      restenosis, and 13% had repeat revascularization. No restenosis was
      observed at the stent edges. Minimum lumen diameter at follow-up averaged
      1.85+/-0.69 mm, which resulted in a late loss of 0.99+/-0. 59 mm and a
      late loss index of 0.53+/-0.35. No other major cardiac events occurred
      during the 6-month follow-up. CONCLUSIONS: The use of radioactive stents
      with an activity of 0.75 to 1.5 microCi is safe and feasible.</description>
    </item>
  </channel>
</rss>